This bill aims to establish administration fees under the Arkansas Medicaid Program specifically for immunizations and monoclonal antibodies targeting respiratory syncytial virus (RSV) disease. It introduces a new section to the Arkansas Code that mandates the Medicaid Program to reimburse an administration fee equal to 100% of the maximum fee set by the Vaccines for Children Program for administering these treatments to infants and toddlers. Additionally, the bill clarifies that hospitals are not required to provide new services related to these immunizations and mandates the Department of Human Services to seek any necessary federal waivers or amendments to implement the provisions.

Furthermore, the bill provides civil immunity to individuals or entities involved in the administration of RSV immunizations or monoclonal antibodies, protecting them from civil liability, except in cases of gross negligence or willful misconduct. This new legal language aims to encourage healthcare providers to administer these critical treatments without the fear of legal repercussions, thereby enhancing public health efforts against RSV in young children.